|
US4599152A
(en)
|
1985-05-24 |
1986-07-08 |
Albion Laboratories |
Pure amino acid chelates
|
|
US4863898A
(en)
|
1986-02-06 |
1989-09-05 |
Albion International, Inc. |
Amino acid chelated compositions for delivery to specific biological tissue sites
|
|
US4883658A
(en)
|
1986-04-28 |
1989-11-28 |
Holly Frank J |
Ophthalmic solution for treatment of dry-eye syndrome
|
|
US4804539A
(en)
|
1986-07-28 |
1989-02-14 |
Liposome Technology, Inc. |
Ophthalmic liposomes
|
|
US4914088A
(en)
|
1987-04-02 |
1990-04-03 |
Thomas Glonek |
Dry eye treatment solution and method
|
|
US5278151A
(en)
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
|
US5061815A
(en)
|
1988-07-06 |
1991-10-29 |
Zinpro Corporation |
Metal lysine complexes and method for producing metal lysine complexes
|
|
US5075104A
(en)
|
1989-03-31 |
1991-12-24 |
Alcon Laboratories, Inc. |
Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
|
|
ATE132366T1
(de)
|
1990-05-29 |
1996-01-15 |
Boston Ocular Res |
Zusammensetzung zur behandlung von dry eye erkrankungen
|
|
ZA912797B
(en)
|
1990-05-29 |
1992-12-30 |
Boston Ocular Res |
Dry eye treatment process and solution
|
|
ZA927277B
(en)
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
|
US6887901B1
(en)
|
1993-06-15 |
2005-05-03 |
Brigham & Women's Hospital, Inc. |
Lipoxin compounds and their use in treating cell proliferative disorders
|
|
US5441951A
(en)
|
1994-06-15 |
1995-08-15 |
Brigham & Women's Hospital |
Lipoxin compounds
|
|
US6048897A
(en)
|
1993-06-15 |
2000-04-11 |
Brigham And Women's Hospital |
Lipoxin compounds and their use in treating cell proliferative disorders
|
|
IT1264987B1
(it)
|
1993-12-14 |
1996-10-17 |
Prospa Bv |
Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
|
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
FR2774591B1
(fr)
|
1998-02-12 |
2000-05-05 |
Lipha |
Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
|
|
ES2224634T3
(es)
|
1998-04-29 |
2005-03-01 |
Sumitomo Pharmaceuticals Company, Limited |
Formulacion oral que comprende biguanida y un acido organico.
|
|
JP4526622B2
(ja)
|
1998-10-23 |
2010-08-18 |
北興化学工業株式会社 |
農園芸用種子消毒剤および種子の消毒方法
|
|
JP2000212145A
(ja)
|
1999-01-22 |
2000-08-02 |
Hokko Chem Ind Co Ltd |
Ｎε―アシル―４―オキサリジンおよびその製造用中間体
|
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
|
CN1416341B
(zh)
|
2000-02-04 |
2010-05-05 |
武田药品工业株式会社 |
稳定的乳液组合物
|
|
IL151299A0
(en)
|
2000-02-16 |
2003-04-10 |
Brigham & Womens Hospital |
Aspirin-triggered lipid mediators
|
|
US6491950B1
(en)
|
2000-08-07 |
2002-12-10 |
Kos Pharmaceuticals, Inc. |
Controlled release pharmaceutical composition
|
|
US6667064B2
(en)
|
2000-08-30 |
2003-12-23 |
Pilot Therapeutics, Inc. |
Composition and method for treatment of hypertriglyceridemia
|
|
US6689385B2
(en)
|
2000-11-03 |
2004-02-10 |
Chronorx Llc |
Formulations for the treatment of insulin resistance and type 2 diabetes mellitus
|
|
DE10102050A1
(de)
|
2001-01-17 |
2002-07-18 |
Basf Ag |
Zubereitung zur Verbesserung der Nahrungsverwertung
|
|
EP1406698B1
(en)
|
2001-03-02 |
2008-10-29 |
The Brigham and Women's Hospital |
Lipoxin analogs as novel inhibitors of angiogenesis
|
|
JP4220247B2
(ja)
|
2001-03-29 |
2009-02-04 |
ビーエーエスエフ ソシエタス・ヨーロピア |
共役不飽和グリセリド混合物及びその製造方法
|
|
JP4744081B2
(ja)
|
2001-08-31 |
2011-08-10 |
ラトガーズ， ザ ステイト ユニバーシティ オブ ニュー ジャージー |
植物抽出物を用いて障害を処置するための方法
|
|
CA2465117C
(en)
|
2001-11-06 |
2012-01-03 |
Brigham And Women's Hospital, Inc. |
Lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
|
|
ITMI20012384A1
(it)
|
2001-11-12 |
2003-05-12 |
Quatex Nv |
Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
|
|
AU2003211131A1
(en)
|
2002-02-14 |
2003-09-04 |
Sonus Pharmaceuticals, Inc. |
Metformin salts of lipophilic acids
|
|
US7670612B2
(en)
|
2002-04-10 |
2010-03-02 |
Innercap Technologies, Inc. |
Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
|
|
CA2487274A1
(en)
|
2002-05-06 |
2003-11-13 |
Nucleonics Inc. |
Spermine chemically linked to lipids and cell-specific targeting molecules as a transfection agent
|
|
US7378444B2
(en)
|
2002-06-17 |
2008-05-27 |
Brigham And Women's Hospital, Inc. |
Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
|
|
WO2004004693A1
(en)
|
2002-07-05 |
2004-01-15 |
Collgegium Pharmaceutical |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
|
AU2003261298A1
(en)
|
2002-08-02 |
2004-02-23 |
Penwest Pharmaceuticals Company |
Sustained release formulations of metformin
|
|
US7759395B2
(en)
|
2002-08-12 |
2010-07-20 |
The Brigham And Women's Hospital, Inc. |
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
|
|
EP1558237A4
(en)
|
2002-09-27 |
2007-01-17 |
Martek Biosciences Corp |
IMPROVED BLOOD SUGAR CONTROL F RPRU-DIABETES AND / OR DIABETES TYPE II USING DOCOSAHEXAENSURE
|
|
US7547454B2
(en)
|
2002-11-07 |
2009-06-16 |
Shyam K Gupta |
Hydroxy acid complexes for antiaging and skin renovation
|
|
JP2004175790A
(ja)
|
2002-11-12 |
2004-06-24 |
Arita Junichi |
α−グルコシダーゼ阻害作用を有する亜鉛含有物
|
|
ITMI20022394A1
(it)
|
2002-11-13 |
2004-05-14 |
Bracco Spa |
Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
|
|
CA2516142A1
(en)
|
2003-03-18 |
2004-09-30 |
Novartis Ag |
Compositions comprising fatty acids and amino acids
|
|
US20050013854A1
(en)
|
2003-04-09 |
2005-01-20 |
Mannino Raphael J. |
Novel encochleation methods, cochleates and methods of use
|
|
EP1510208A1
(en)
|
2003-08-22 |
2005-03-02 |
Fournier Laboratories Ireland Limited |
Pharmaceutical composition comprising a combination of metformin and statin
|
|
US20080045559A1
(en)
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
CA2543722C
(en)
|
2003-10-29 |
2011-01-04 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
RU2006118801A
(ru)
|
2003-10-31 |
2007-12-10 |
Алза Корпорейшн (Us) |
Композиции и лекарственные формы для усиления всасывания габапентина и прегабалина
|
|
EP1708707A1
(en)
|
2004-01-22 |
2006-10-11 |
Neurosearch A/S |
Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
|
|
GB0403247D0
(en)
|
2004-02-13 |
2004-03-17 |
Tillotts Pharma Ag |
A pharmaceutical composition
|
|
EP1591114A1
(en)
|
2004-03-12 |
2005-11-02 |
Fournier Laboratories Ireland Limited |
Use of metformin and orlistat for the treatment or prevention of obesity
|
|
US20060003976A1
(en)
|
2004-06-04 |
2006-01-05 |
Yuehua Zhang |
Cholesterol/bile acid/bile acid derivative-modified therapeutic drug compounds
|
|
TWI236573B
(en)
|
2004-07-09 |
2005-07-21 |
Asia Optical Co Inc |
Camera lens with adjustment mechanism
|
|
EP1804815A2
(en)
|
2004-10-29 |
2007-07-11 |
Joan Campell-Tofte |
Anti-diabetic extract isolated from rauvolfia vomitoria and citrus aurantium, and methods of using same
|
|
US20060293288A1
(en)
|
2005-01-07 |
2006-12-28 |
Serhan Charles N |
Use of resolvins to treat gastrointestinal diseases
|
|
JP5337479B2
(ja)
|
2005-05-04 |
2013-11-06 |
プロノヴァ・バイオファーマ・ノルゲ・アーエス |
新規化合物
|
|
EP1898922A4
(en)
|
2005-07-04 |
2012-03-14 |
Ramu Krishnan |
MEDICINE OR IMPROVED PHARMACEUTICAL COMPOUNDS AND PREPARATION THEREOF
|
|
WO2007041440A2
(en)
*
|
2005-10-03 |
2007-04-12 |
The Brigham And Women's Hospital, Inc. |
Anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers
|
|
EP1960356A2
(en)
|
2005-11-03 |
2008-08-27 |
Ilypsa, Inc. |
Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors
|
|
EP1984355A2
(en)
|
2006-02-16 |
2008-10-29 |
Takeda Pharmaceutical Company Limited |
Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension
|
|
US20090047340A1
(en)
|
2006-03-29 |
2009-02-19 |
Guilford F Timothy |
Liposomal reduced glutathione and 1-arginine, including with other ingredient(s), capable of multipath administration for reversal and prevention of obesity and for mitochondrial biogenesis
|
|
CN101522658A
(zh)
|
2006-06-16 |
2009-09-02 |
因迪基恩药物公司 |
作为抗糖尿病药用于控制糖尿病高血糖症和糖尿病并发症的二甲双胍r-(+)硫辛酸盐
|
|
US20120189569A1
(en)
|
2006-08-06 |
2012-07-26 |
Bioderm Research |
Hydroxy Acid Complexes for Skin Renovation and Clarity
|
|
TW200816991A
(en)
*
|
2006-08-23 |
2008-04-16 |
Bayer Schering Pharma Ag |
Treatment and prevention of intestinal fibrosis
|
|
US8399516B2
(en)
|
2006-11-01 |
2013-03-19 |
Pronova Biopharma Norge As |
Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (PPAR)
|
|
WO2008058274A2
(en)
|
2006-11-09 |
2008-05-15 |
Children's Medical Center Corporation |
Use of resolvins and docosatrienes and analogues thereof for the treatment of angiogenesis and ocular neovascularization
|
|
US7906678B2
(en)
*
|
2006-12-04 |
2011-03-15 |
Bayer Schering Pharma Aktiengesellschaft |
Crystalline potassium salt of lipoxin A4 analogs
|
|
WO2008093984A1
(en)
|
2007-01-29 |
2008-08-07 |
Hanall Pharmaceutical Company. Ltd |
N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
|
|
TW200904433A
(en)
|
2007-04-27 |
2009-02-01 |
Takeda Pharmaceutical |
Substituted imidazole compound and use thereof
|
|
US20090227560A1
(en)
|
2007-04-27 |
2009-09-10 |
Takanobu Kuroita |
Substituted imidazole compound and use thereof
|
|
US20090054513A1
(en)
|
2007-08-22 |
2009-02-26 |
Response Scientific, Inc. |
Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
|
|
JP5292404B2
(ja)
|
2007-09-21 |
2013-09-18 |
ハンオル バイオファーマ カンパニー，リミテッド |
Ｎ，ｎ−ジメチルイミドジカルボンイミド酸ジアミドのジカルボン酸塩、その製造方法、及びその薬剤学的組成物
|
|
EP2202228B1
(en)
|
2007-10-15 |
2014-12-10 |
Takeda Pharmaceutical Company Limited |
Amide compounds and use of the same
|
|
CA2723434C
(en)
|
2008-05-05 |
2018-01-23 |
Oramed Ltd. |
Methods and compositions for oral administration of exenatide
|
|
SG188117A1
(en)
|
2008-06-19 |
2013-03-28 |
Takeda Pharmaceutical |
Heterocyclic compound and use thereof
|
|
JP5551691B2
(ja)
|
2008-06-26 |
2014-07-16 |
ラボラトリオス シラネス、エセ．ア．デ セ．べ． |
血糖制御のための新規グリシン酸メトホルミン塩
|
|
FR2934519B1
(fr)
|
2008-08-01 |
2013-06-28 |
Oreal |
Procede de fabrication d'un premier recipient de produit cosmetique, moule, col et recipient associes
|
|
CN107233337A
(zh)
|
2009-04-29 |
2017-10-10 |
阿马里纳药物爱尔兰有限公司 |
含有epa和心血管剂的药物组合物以及使用其的方法
|
|
BRPI1011883A2
(pt)
|
2009-06-15 |
2016-09-13 |
Amarin Pharma Inc |
uso de composições para redução de triglicerídeos sem elevar os níveis de o ldl-c em um paciente sob o tratamento concomitante com estatina
|
|
US20120245229A1
(en)
|
2009-09-15 |
2012-09-27 |
Ru-Rong Ji |
Method for treating neuropathic pain
|
|
PL217815B1
(pl)
|
2009-12-14 |
2014-08-29 |
Olimp Lab Spółka Z Ograniczoną Odpowiedzialnością |
Napój izotoniczny z chelatami
|
|
US8178707B2
(en)
|
2010-03-25 |
2012-05-15 |
Jost Chemical Company |
Co-precipitated salts of fatty acids
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
US8796338B2
(en)
|
2011-01-07 |
2014-08-05 |
Elcelyx Therapeutics, Inc |
Biguanide compositions and methods of treating metabolic disorders
|
|
US20120178813A1
(en)
|
2011-01-12 |
2012-07-12 |
Thetis Pharmaceuticals Llc |
Lipid-lowering antidiabetic agent
|
|
WO2012141316A1
(ja)
|
2011-04-13 |
2012-10-18 |
味の素株式会社 |
栄養組成物
|
|
CN107050457A
(zh)
|
2012-01-06 |
2017-08-18 |
翁特拉制药公司 |
游离酸形式的ω‑3多不饱和脂肪酸的富含dpa组合物
|
|
WO2013134431A1
(en)
|
2012-03-06 |
2013-09-12 |
Life Technologies Corporation |
Biomarkers for systemic lupus erythematosus
|
|
AU2013259503B2
(en)
|
2012-05-10 |
2017-03-16 |
Solutex Na Llc |
Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
|
|
WO2013192109A1
(en)
|
2012-06-17 |
2013-12-27 |
Matinas Biopharma, Inc. |
Omega-3 pentaenoic acid compositions and methods of use
|
|
US20140011814A1
(en)
|
2012-07-06 |
2014-01-09 |
Thetis Pharmaceuticals Llc |
Diamine and meglumine salt forms of fatty acids
|
|
US8765811B2
(en)
|
2012-07-10 |
2014-07-01 |
Thetis Pharmaceuticals Llc |
Tri-salt form of metformin
|
|
BR112015000368A2
(pt)
|
2012-07-10 |
2017-06-27 |
Thetis Pharmaceuticals Llc |
forma de tri-sais de metformina
|
|
WO2014011895A2
(en)
|
2012-07-11 |
2014-01-16 |
Thetis Pharmaceuticals Llc |
High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof
|
|
AU2012227298B2
(en)
|
2012-09-25 |
2015-02-12 |
Jost Chemical Co. |
Co-precipitated salts of fatty acids
|
|
TW201416726A
(zh)
|
2012-10-26 |
2014-05-01 |
Dongguan Masstop Liquid Crystal Display Co Ltd |
具有觸控功能之彩色濾光片基板
|
|
US9394318B2
(en)
|
2012-11-30 |
2016-07-19 |
Cypress Pharmaceuticals, Inc. |
Crystal polymorph of magnesium glycinate dihydrate and process for its preparation
|
|
CN103340300A
(zh)
|
2013-06-06 |
2013-10-09 |
李才平 |
一种绿色生态鲫鱼饲料的配制方法
|
|
WO2015171516A1
(en)
|
2014-05-05 |
2015-11-12 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to ionic salts of peptides
|
|
CN107074884A
(zh)
*
|
2014-06-18 |
2017-08-18 |
西蒂斯制药有限责任公司 |
活性剂的矿物质氨基酸复合物
|
|
US9242008B2
(en)
*
|
2014-06-18 |
2016-01-26 |
Thetis Pharmaceuticals Llc |
Mineral amino-acid complexes of fatty acids
|
|
CN104430341B
(zh)
|
2014-12-10 |
2016-09-28 |
青岛大学 |
天然有机酸根褐藻氨酸螯合物在农用制剂中的应用
|
|
WO2017041094A1
(en)
|
2015-09-03 |
2017-03-09 |
Solutex Na Llc |
Compositions comprising omega-3 fatty acids, 17-hdha and 18- hepe and methods of using same
|
|
GB201522132D0
(en)
|
2015-12-15 |
2016-01-27 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
KR102437682B1
(ko)
|
2016-06-03 |
2022-08-29 |
테티스 파마수티컬스 엘엘씨 |
특화된 사전 해소 매개체의 염에 관한 조성물 및 방법
|